Takeda Pharmaceutical Co. Ltd., 10% Owner at Phathom Pharmaceuticals, Inc. (PHAT), sold 5,395 shares at $35.14 ($190K) on 2021-06-10, disclosed to the SEC on 2021-06-11.
Open-market sale of $190k PHAT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.28 | 1,191 | $42K | 22.1% |
| 2 | $35.14 | 2,102 | $74K | 38.9% |
| 3 | $35.14 | 2,102 | $74K | 38.9% |
| Total | $35.17 avg | 5,395 | $190K | 100% |
| Filing → |
| DAWN | SELL | 2021-12-09 | $9.9M | — | Filing → |
| PHAT | SELL | 2021-11-08 | $20.9M | — | Filing → |
| PHAT | SELL | 2021-07-09 | $183K | — | Filing → |